Uncategorized

Applied Therapeutics to Present Data on AT-007 for the Treatment of Galactosemia at the American Society of Human Genetics (ASHG) 2020 Annual Meeting

Content Editor October 21, 2020

FDA Grants AT-007 Pediatric Rare Disease Designation and Orphan Designation for Treatment of PMM2-CDG

Content Editor September 24, 2020

Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the European Association for the Study of Diabetes

Content Editor September 17, 2020

Applied Therapeutics to Present at Citi and Baird Investor Conferences

Content Editor September 2, 2020